What's Happening
President Trump signed an executive order reducing recommended childhood vaccinations and encouraging parental choice, prompting immediate condemnation from doctors and public health officials. The move comes as the U.S. faces its worst measles outbreak in decades as children return to school.
Market Impact
Vaccine manufacturers including Moderna and Pfizer face potential demand headwinds if immunization rates decline. Healthcare providers and insurers may also face increased costs from preventable disease outbreaks, offsetting any near-term savings.
Broader Implications
The order reflects broader skepticism toward public health institutions and could weaken disease surveillance and prevention infrastructure. A measles resurgence would strain hospital systems and reverse decades of immunization progress.